Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Junwon Lee, Myung Eun Jung & Jinhwa Lee. (2010) 5-HT2C receptor modulators: a patent survey. Expert Opinion on Therapeutic Patents 20:11, pages 1429-1455.
Read now
Read now
E. Pretorius
. (2005) Asthma medication and the role of serotonin in the development of cognitive and psychological difficulties. Early Child Development and Care 175:2, pages 139-151.
Read now
Read now
Sean D Hood, Spilios V Argyropoulos & David J Nutt. (2003) New directions in the treatment of anxiety disorders. Expert Opinion on Therapeutic Patents 13:4, pages 401-423.
Read now
Read now
Articles from other publishers (27)
Haoran WANG, Yanqiu GU, Rahman KHALID, Xiaofei CHEN & Ting HAN. (2023) Herbal medicines for insomnia through regulating 5-hydroxytryptamine receptors: a systematic review. Chinese Journal of Natural Medicines 21:7, pages 483-498.
Crossref
Crossref
Valeria Tellone, Maria Teresa Rosignoli, Rossella Picollo, Patrizia Dragone, Alessandra Del Vecchio, Alessandro Comandini, Milko Radicioni, Chiara Leuratti & Fabrizio Calisti. (2020) Effect of 3 Single Doses of Trazodone on QTc Interval in Healthy Subjects. The Journal of Clinical Pharmacology 60:11, pages 1483-1495.
Crossref
Crossref
Veeramachaneni, Thunuguntla, Bhaswant, Mathai & Bondili. (2019) Pharmacophore Directed Screening of Agonistic Natural Molecules Showing Affinity to 5HT2C Receptor. Biomolecules 9:10, pages 556.
Crossref
Crossref
Pedro Merino. 2019. Chemical Biology of Neurodegeneration. Chemical Biology of Neurodegeneration
81
120
.
Abu Hasanat Md. Zulfiker, Saeed M. Hashimi, David A. Good, I. Darren Grice & Ming Q. Wei. (2017)
Cane Toad Skin Extract-Induced Upregulation and Increased Interaction of Serotonin 2A and D
2
Receptors via G
q/11
Signaling Pathway in CLU213 Cells
. Journal of Cellular Biochemistry 118:5, pages 979-993.
Crossref
Crossref
Benjamin G. Tehan, Andrea Bortolato, Frank E. Blaney, Malcolm P. Weir & Jonathan S. Mason. (2014) Unifying Family A GPCR Theories of Activation. Pharmacology & Therapeutics 143:1, pages 51-60.
Crossref
Crossref
Jae Wan Jang, Min Sup Kim, Yong Seo Cho, Art E. Cho & Ae Nim Pae. (2012) Identification of structural determinants of ligand selectivity in 5-HT2 receptor subtypes on the basis of protein–ligand interactions. Journal of Molecular Graphics and Modelling 38, pages 342-353.
Crossref
Crossref
John A. Allen & Bryan L. Roth. (2011) Strategies to Discover Unexpected Targets for Drugs Active at G Protein–Coupled Receptors. Annual Review of Pharmacology and Toxicology 51:1, pages 117-144.
Crossref
Crossref
Donald J. AbrahamJeffrey M. Brown, Jie Jack Li & Michael W. Sinz. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
161
218
.
Sung Jin ChoNiels H. JensenToru KuromeSudhakar KadariMichael L. ManzanoJessica E. MalbergBarbara CaldaroneBryan L. RothAlan P. Kozikowski. (2009) Selective 5-Hydroxytryptamine 2C Receptor Agonists Derived from the Lead Compound Tranylcypromine: Identification of Drugs with Antidepressant-Like Action. Journal of Medicinal Chemistry 52:7, pages 1885-1902.
Crossref
Crossref
John A. Allen, Prem N. Yadav & Bryan L. Roth. (2008) Insights into the regulation of 5-HT2A serotonin receptors by scaffolding proteins and kinases. Neuropharmacology 55:6, pages 961-968.
Crossref
Crossref
Zhili Zuo, Gang Chen, Xiaomin Luo, Chummok Puah, Weiliang Zhu, Kaixian Chen & Hualiang Jiang. (2007) Pharmacophore-directed Homology Modeling and Molecular Dynamics Simulation of G Protein-coupled Receptor: Study of Possible Binding Modes of 5-HT<sub>2C</sub> Receptor Agonists. Acta Biochimica et Biophysica Sinica 39:6, pages 413-422.
Crossref
Crossref
Kelly A. Berg, Sylvia Navailles, Teresa A. Sanchez, Yamille M. Silva, Martyn D. Wood, Umberto Spampinato & William P. Clarke. (2006)
Differential Effects of 5-Methyl-1-[[2-[(2-methyl-3-pyridyl)oxyl]-5-pyridyl]carbamoyl]-6-trifluoromethylindone (SB 243213) on 5-Hydroxytryptamine
2C
Receptor-Mediated Responses
. Journal of Pharmacology and Experimental Therapeutics 319:1, pages 260-268.
Crossref
Crossref
Ola M. Ghoneim, Jacqueline A. Legere, Alexander Golbraikh, Alexander Tropsha & Raymond G. Booth. (2006) Novel ligands for the human histamine H1 receptor: Synthesis, pharmacology, and comparative molecular field analysis studies of 2-dimethylamino-5-(6)-phenyl-1,2,3,4-tetrahydronaphthalenes. Bioorganic & Medicinal Chemistry 14:19, pages 6640-6658.
Crossref
Crossref
Bryan Roth. (2006) 5-Hydroxytryptamine receptor 2A. AfCS-Nature Molecule Pages.
Crossref
Crossref
Kerry A. O'Connor & Bryan L. Roth. (2005) Finding New Tricks For Old Drugs: An Efficient Route For Public-Sector Drug Discovery. Nature Reviews Drug Discovery 4:12, pages 1005-1014.
Crossref
Crossref
Kelly A. Berg, John A. Harvey, Umberto Spampinato & William P. Clarke. (2005) Physiological relevance of constitutive activity of 5-HT2A and 5-HT2C receptors. Trends in Pharmacological Sciences 26:12, pages 625-630.
Crossref
Crossref
Howard Sard, Govindaraj Kumaran, Cynthia Morency, Bryan L. Roth, Beth Ann Toth, Ping He & Louis Shuster. (2005) SAR of psilocybin analogs: Discovery of a selective 5-HT2C agonist. Bioorganic & Medicinal Chemistry Letters 15:20, pages 4555-4559.
Crossref
Crossref
Anil Purohit, Carol Smith, Katharine Herrick-Davis & Milt Teitler. (2004) Stable expression of constitutively activated mutant h5HT6 and h5HT7 serotonin receptors: inverse agonist activity of antipsychotic drugs. Psychopharmacology 179:2, pages 461-469.
Crossref
Crossref
Maud Deraet, Philippe Manivet, Agnes Janoshazi, Jacques Callebert, Silke Guenther, Ludovic Drouet, Jean-Marie Launay & Luc Maroteaux. (2005)
The Natural Mutation Encoding a C Terminus-Truncated 5-Hydroxytryptamine
2B
Receptor Is a Gain of Proliferative Functions
. Molecular Pharmacology 67:4, pages 983-991.
Crossref
Crossref
Bryan L Roth, Estela Lopez, Scott Beischel, Richard B Westkaemper & Jon M Evans. (2004) Screening the receptorome to discover the molecular targets for plant-derived psychoactive compounds: a novel approach for CNS drug discovery. Pharmacology & Therapeutics 102:2, pages 99-110.
Crossref
Crossref
L. Costa-Campos, S.C. Dassoler, A.P. Rigo, M. Iwu & E. Elisabetsky. (2004) Anxiolytic properties of the antipsychotic alkaloid alstonine. Pharmacology Biochemistry and Behavior 77:3, pages 481-489.
Crossref
Crossref
Ε. Pretorius. (2004) Corticosteroids, Depression and the Role of Serotonin. Reviews in the Neurosciences 15:2.
Crossref
Crossref
Michael D Ennis, Robert L Hoffman, Nabil B Ghazal, Rebecca M Olson, Christopher S Knauer, Chris L Chio, Deborah K Hyslop, Jeffery E Campbell, Lawrence W Fitzgerald, Nanette F Nichols, Kjell A Svensson, Robert B McCall, Christopher L Haber, Michelle L Kagey & Dac M Dinh. (2003) 2,3,4,5-Tetrahydro- and 2,3,4,5,11,11a-hexahydro-1H-[1,4]diazepino[1,7-a]indoles: new templates for 5-HT2C agonists. Bioorganic & Medicinal Chemistry Letters 13:14, pages 2369-2372.
Crossref
Crossref
Bryan L Roth, Douglas Sheffler & Steven G Potkin. (2003) Atypical antipsychotic drug actions: unitary or multiple mechanisms for ‘atypicality’?. Clinical Neuroscience Research 3:1-2, pages 108-117.
Crossref
Crossref
Kateri A. Ahrendt, Robert G. Bergman & Jonathan A. Ellman. (2003) Synthesis of a Tricyclic Mescaline Analogue by Catalytic C−H Bond Activation. Organic Letters 5:8, pages 1301-1303.
Crossref
Crossref
David A. Shapiro, Kurt Kristiansen, David M. Weiner, Wesley K. Kroeze & Bryan L. Roth. (2002) Evidence for a Model of Agonist-induced Activation of 5-Hydroxytryptamine 2A Serotonin Receptors That Involves the Disruption of a Strong Ionic Interaction between Helices 3 and 6. Journal of Biological Chemistry 277:13, pages 11441-11449.
Crossref
Crossref